Inhaled budesonide in the treatment of early COVID-19 illness: a randomised controlled trial
Sanjay Ramakrishnan(The University of Western Australia), Mona Bafadhel(National Institute for Health and Care Excellence), Dan V. Nicolau(Queensland University of Technology), Robin Fox(Bicester Community Hospital), Peter J. Barnes(Imperial College London), Richard Russell(Southern Health NHS Foundation Trust), Philippa C. Matthews(University of Oxford), Helen Jeffers(National Institute for Health and Care Research), Christine Mwasuku(National Institute for Health and Care Research), Mahdi Mahdi(National Institute for Health and Care Research), Nabil T. Fadai(University of Nottingham), Ian Binnian, Stephen Bright, Jennifer Cane(National Institute for Health and Care Research), Andreas Halner(University of Oxford), Jodie L. Simpson(Hunter Medical Research Institute), Christopher Butler(West Virginia School of Osteopathic Medicine), Stefan Peterson(WeMind), Karolina Krassowska(National Institute for Health and Care Research), Thomas Bengtsson(WeMind), Beverly Langford(National Institute for Health and Care Research), Victoria Glover(Horse Hospital), Jonathan Baker(Lung Institute), Louise Donnelly(Lung Institute)
Cited by 25
Related Papers
The cytokine network in asthma and chronic obstructive pulmonary disease
|Journal of Clinical Investigation|2008|968
Inflammatory subtypes in asthma: Assessment and identification using induced sputum
|Respirology|2006|939
Outcomes for COPD pharmacological trials: from lung function to biomarkers
|European Respiratory Journal|2008|856
How corticosteroids control inflammation: Quintiles Prize Lecture 2005
|British Journal of Pharmacology|2006|812
Chronic obstructive pulmonary disease
|Nature Reviews Disease Primers|2015|733